SOW
ALNY icon

State of Wyoming’s Alnylam Pharmaceuticals ALNY Stock Holding History

State of Wyoming’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-94
Closed -$16K – 1779
2021
Q4 		$16K Sell
94
-47
-33% -$8.73K 0.01% 1557
2021
Q3 		$27K Sell
141
-281
-67% -$52.7K 0.02% 892
2021
Q2 		$72K Buy
422
+168
+66% +$24.6K 0.05% 596
2021
Q1 		$36K Buy
+254
New +$38.2K 0.06% 258

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State of Wyoming's ALNY Position: Q1 2022 in Review

State of Wyoming sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2022, closing a stake of 94 shares — an estimated $16K sold.

State of Wyoming first reported a position in ALNY in Q1 2021 and held it in 4 quarters. The position peaked at $72K in Q2 2021. 443 funds tracked by Wall St. Rank hold ALNY as of Q1 2022.

  • State of Wyoming reported no remaining Alnylam Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • State of Wyoming sold 94 Alnylam Pharmaceuticals shares in Q1 2022, an estimated $16K.
  • State of Wyoming first reported a position in Alnylam Pharmaceuticals in Q1 2021 and held it in 4 quarters.
  • State of Wyoming's Alnylam Pharmaceuticals position peaked at $72K in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2022.

Based on State of Wyoming's 13F filing for Q1 2022, filed 13 May 2022.